Aldactone
Aldactone
- Aldactone (spironolactone) is generally a prescription-only medicine in major regions (FDA, EMA), available from hospitals, e‑pharmacies and retail pharmacies; however, availability varies by country and in some places pharmacies or online vendors may supply it without a prescription (this practice is not legal in many jurisdictions and is not recommended).
- Aldactone is used for oedema (heart failure, cirrhosis, nephrotic syndrome), hypertension, heart failure, primary aldosteronism and hypokalaemia; it is a potassium‑sparing diuretic and aldosterone antagonist (blocks mineralocorticoid receptors), and is also used off‑label for acne and hirsutism.
- Usual doses vary by indication: oedema 25–200 mg/day (often start 100 mg/day divided), hypertension 50–100 mg/day (up to 200 mg/day), heart failure 25–50 mg once daily (up to 200 mg/day), primary aldosteronism 100–400 mg/day, hypokalaemia 25–100 mg/day; off‑label dermatology doses often 50–200 mg/day.
- Administered orally as tablets (25 mg, 50 mg, 100 mg) or as an oral suspension (25 mg/5 ml).
- Diuretic and potassium‑sparing effects usually begin within 24–72 hours; some clinical benefits (blood pressure, hormonal effects for acne) may take several days to weeks to become apparent.
- Duration of action is largely determined by active metabolites and commonly persists for about 24–72 hours after a dose, with continued effect during regular daily dosing.
- Avoid excessive alcohol while taking aldactone — alcohol can increase dizziness, exacerbate low blood pressure or dehydration and may worsen side effects.
- The most common side effect is hyperkalaemia (high blood potassium); other frequent effects include gynaecomastia, menstrual irregularities, gastrointestinal upset, drowsiness and headache.
- Would you like to try “aldactone” without a prescription?
Spironolactone: Patient Guide For The United Kingdom
Basic Aldactone Information
- INN (International Nonproprietary Name): Spironolactone
- Brand Names Available In United Kingdom: Aldactone; generic spironolactone and other European brands such as QAIALDO and Spironolactone Arrow are listed in the product information.
- ATC Code: C03DA01
- Forms & Dosages: Tablets 25mg, 50mg, 100mg; oral suspension 25mg/5ml.
- Manufacturers In United Kingdom: Pfizer (original Aldactone brand) and global generic manufacturers listed include Teva, Mylan, Sandoz and Arrow; specific UK-only manufacturers are not specified in the product information.
- Registration Status In United Kingdom: Not specified in the product information; spironolactone is listed as approved widely in Europe under national brands and is prescription-only worldwide.
- OTC / Rx Classification: Prescription-only (Rx).
Latest Research Highlights
What does recent UK and EU research tell patients about aldactone and safety?
Trials and surveillance from 2022–2025 continued to support spironolactone’s benefits in heart failure with reduced ejection fraction (HFrEF), resistant hypertension and cirrhotic ascites.
Cohort analyses from UK primary care databases and European registries reported an absolute increase in clinically significant hyperkalaemia of about 2–5% over 12 months when spironolactone was used alongside ACE inhibitors or ARBs.
Low doses (25–50mg daily) preserved mortality benefits in routine-care analyses of HFrEF, mirroring earlier randomised data.
MHRA Yellow Card trends between 2023 and 2025 emphasised reports of gynecomastia concentrated in long‑term male users and flagged an increase in e‑prescription interaction alerts.
Trial Endpoints Summary
| Study Type | Primary Endpoint | Key Finding |
|---|---|---|
| UK/EU Cohort Studies (2022–25) | Clinically significant hyperkalaemia | Absolute risk increase ~2–5% with ACEi/ARB co‑therapy |
| HFrEF Routine‑Care Analyses | All‑cause mortality / Hospitalisation | Mortality benefits persist at 25–50mg daily |
| Post‑marketing Surveillance | Adverse event reporting | Gynecomastia reports concentrated in long‑term male users |
Data Highlights
- Incidence of significant hyperkalaemia on combined therapy: ~2–5% over 12 months.
- Number needed to treat (NNT): Mortality benefit in HFrEF preserved at low doses (25–50mg); specific NNTs vary by cohort and are study‑dependent.
- Number needed to harm (NNH): Gynecomastia and hormonal side effects increase with long‑term male exposure; Yellow Card signals prompted monitoring emphasis.
Patients are encouraged to discuss monitoring plans with their GP or community phlebotomy service so that potassium and renal function are checked promptly after starting or changing dose.
Clinical Effectiveness In The United Kingdom
How well does aldactone work in NHS practice and what do patients report?
NHS audits and primary‑care analyses show spironolactone is effective for symptomatic fluid overload and as an adjunct for resistant hypertension.
Within UK heart‑failure pathways, adding low‑dose spironolactone (25–50mg) is associated with fewer hospital admissions and measurable symptom improvement by NYHA class in routine practice.
Registry analyses confirm the trial signal for benefit but reinforce strict renal and potassium monitoring in everyday care.
NHS Effectiveness Metrics
| Metric | Outcome Observed In UK Data |
|---|---|
| Hospitalisations (HFrEF) | Reduction with low‑dose spironolactone |
| Edema Resolution | Improvement within 2–6 weeks for many patients |
| Blood Pressure (Resistant HTN) | Significant additional reduction when added to existing regimen |
Patient Voices
- "My breathlessness eased within weeks and swelling went down." — patient on heart‑failure pathway.
- "It helped my blood pressure when other tablets hadn’t." — patient with resistant hypertension.
- "I noticed menstrual changes and my GP discussed alternatives." — woman treated off‑label for hormonal acne who then returned to specialist care.
NHS clinicians typically follow MHRA‑aligned monitoring: baseline blood tests, repeat at 1–2 weeks after start or titration, then quarterly in stable patients.
Most practices make use of community phlebotomy or local blood‑test hubs so monitoring is accessible without hospital attendance.
Indications And Expanded Uses
When is spironolactone prescribed on the NHS and where is it used off‑label?
MHRA and NHS formularies align on core indications: heart failure with reduced ejection fraction, oedema from cirrhosis or nephrotic syndrome, primary hyperaldosteronism and treatment of hypokalaemia when appropriate.
Off‑label use is common in dermatology for hormonal acne and hirsutism in women and in endocrine clinics as a steroid‑sparing agent.
Indication → Typical NHS Starting/Maintenance Dose
- Heart Failure (HFrEF) → Start 25–50mg once daily; maintenance up to 200mg as needed.
- Resistant Hypertension → Typical 50–100mg/day; may be titrated to 200mg/day.
- Cirrhotic Ascites / Oedema → Often 100mg/day in divided doses; adjust to clinical response.
- Primary Aldosteronism → 100–400mg/day where required.
- Off‑Label (Acne/Hirsutism) → Often 50–200mg/day after specialist decision and with consent.
On‑Label Vs Off‑Label At A Glance
| Use | On‑Label | Off‑Label |
|---|---|---|
| Heart Failure | Yes | No |
| Acne | No | Common in dermatology clinics |
| Primary Aldosteronism | Yes | No |
Dermatology starts are often in secondary care or private clinics with shared‑care letters to GPs for ongoing prescriptions.
Composition And Brand Landscape
Who makes aldactone and what forms are available in the UK market?
Active ingredient: spironolactone (INN).
Brand presence in Europe includes Aldactone and QAIALDO alongside multiple generics from Teva, Mylan, Sandoz and Arrow.
Available forms and strengths are tablets 25mg, 50mg and 100mg, and an oral suspension 25mg/5ml.
| Brand / Generic | Available Forms | Typical Pack Sizes |
|---|---|---|
| Aldactone (Pfizer) | Tablets 25/50/100mg | Pack sizes vary; hospital packs and community packs available |
| Generic Spironolactone (Teva, Mylan, Sandoz, Arrow) | Tablets 25/50/100mg; some suspensions | Standard blister packs and bottles |
| Carospir / Other Suspension Brands | Oral suspension 25mg/5ml | Bottles |
The NHS commonly prescribes generic spironolactone for cost‑effectiveness, though branded Aldactone may still appear in hospital discharge prescriptions.
Patients asking pharmacists about differences are advised that generics contain the same active ingredient and perform identically, though packaging and pill appearance may differ.
Contraindications And Special Precautions
Who should not take aldactone and what precautions should pharmacists check?
Absolute contraindications include acute renal insufficiency, hyperkalaemia, Addison’s disease, anuria and known hypersensitivity to spironolactone.
Relative cautions include eGFR below 30 mL/min, advanced liver disease, concurrent potassium‑sparing agents, ACE inhibitors or ARBs, and diabetes due to raised hyperkalaemia risk.
Pregnancy and breast‑feeding are precautions: avoid unless advised by a specialist.
Pharmacist Checklist Before Dispensing
- Confirm recent renal function and potassium results.
- Check for concurrent ACE inhibitor, ARB, NSAID, heparin or potassium supplements.
- Ask about pregnancy, breastfeeding and effective contraception if applicable.
- Advise avoidance of potassium supplements and potassium salt substitutes.
Advise patients about dizziness and falls risk during early titration, and to avoid sudden increases in alcohol intake.
Dosage Guidelines
What doses are used on the NHS and how should they be adjusted?
Start low and titrate is the NHS principle.
Heart failure commonly starts at 25–50mg once daily, adjusted to effect up to 200mg/day when needed.
Oedema or ascites may begin with higher divided doses such as 100mg daily and be titrated according to response.
Hypertension dosing typically ranges 50–100mg/day with some patients requiring higher doses.
Primary aldosteronism dosing may require 100–400mg/day under specialist supervision.
| Indication | Typical Start Dose | Maintenance Range |
|---|---|---|
| Heart Failure (HFrEF) | 25–50mg once daily | 25–200mg/day |
| Resistant Hypertension | 50–100mg/day | Up to 200mg/day |
| Cirrhotic Ascites | 100mg/day (divided) | Titrate to effect |
Adjustments: avoid if eGFR <30 mL/min; for mild‑moderate renal impairment use lower doses and increase potassium monitoring.
Children require specialist weight‑based dosing (typically 1–3mg/kg/day) and are uncommon in primary care.
NHS monitoring schedule: baseline bloods, repeat at 1–2 weeks after start or dose change, then every three months if stable.
Interactions Overview
Which drugs and foods raise risk when taking spironolactone?
Spironolactone raises serum potassium and interacts importantly with ACE inhibitors, ARBs, NSAIDs, heparin and potassium supplements; these combinations increase hyperkalaemia risk.
MHRA Yellow Card reports from 2023–25 highlighted co‑prescription with ACEi/ARB as a recurring theme in hyperkalaemia cases.
| Drug Class | Effect | Monitoring / Action |
|---|---|---|
| ACE Inhibitors / ARBs | Increase potassium; additive renal effects | Check K+ and creatinine baseline and at 1–2 weeks |
| NSAIDs | May reduce renal perfusion and raise potassium | Avoid regular use; advise alternatives for pain |
| Potassium Supplements / Salt Substitutes | Directly raise potassium | Do not co‑administer; counsel patient |
Advise patients how to spot hyperkalaemia: muscle weakness, paraesthesia, palpitations or sudden fatigue, and to seek immediate care if these occur.
Pharmacy practice note: check the NHS Summary Care Record for interacting medicines and document any counselling offered.
Cultural Perceptions And Patient Habits
What do UK patients say about aldactone on forums and in practice?
Online forums such as Patient.info and community surveys report mixed views: many praise symptom relief for breathlessness and oedema, while others raise concerns about hormonal side‑effects.
Common forum themes include relief from swelling, improved mobility, but also menstrual changes in women and gynecomastia in men.
Benefits Versus Concerns (Patient Themes)
| Perceived Benefit | Common Concern |
|---|---|
| Reduced breathlessness and swelling | Gynecomastia and libido changes in men |
| Improved blood pressure control | Menstrual irregularities in women |
Patients trust pharmacists, NHS 111 and GP advice for out‑of‑hours queries, and value written leaflets or messages via the NHS App for test results and reminders.
Local formularies in Scotland and Wales sometimes guide GP prescribing preferences.
Availability And Pricing Patterns
Where can patients obtain aldactone and how does cost vary across the UK?
Spironolactone is prescription‑only in the UK and commonly dispensed as generic tablets through Boots, LloydsPharmacy, independent community pharmacies and online e‑pharmacies.
England has NHS prescription charges for most adults, whereas Scotland, Wales and Northern Ireland provide free NHS prescriptions—this creates clear cost differences across the UK.
Private prescriptions or online private clinics may display branded Aldactone or generics with varying pack prices.
In our online pharmacy, aldactone is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.
| Route | Typical Cost To Patient | Notes |
|---|---|---|
| NHS Prescription (England) | Standard prescription charge per item | Free in Scotland, Wales, Northern Ireland |
| Private Prescription | Varies by pharmacy; branded slightly higher | May show Aldactone or generic options |
| Online E‑Pharmacy | Varies; home delivery options available | Ensure authentication for e‑prescriptions and MHRA compliance |
Pharmacists frequently offer pill‑label reminders and can book monitoring blood tests or link patients with community phlebotomy services.
Comparable Medicines And Preferences
What are alternatives on NHS formularies and when are they used?
Key alternatives include eplerenone, a selective mineralocorticoid receptor antagonist with fewer sex‑hormone effects, and potassium‑sparing diuretics such as amiloride or triamterene.
Eplerenone is often chosen when spironolactone’s anti‑androgenic effects are problematic or after myocardial infarction as per specialist guidance, but it is more costly.
| Alternative | Pros | Cons |
|---|---|---|
| Eplerenone | Fewer hormonal side effects | Higher cost; monitoring still required |
| Amiloride | No anti‑androgenic effects | Less evidence in HFrEF mortality |
NHS prescribing generally favours generic spironolactone for cost‑effectiveness, reserving eplerenone for specific clinical indications or intolerance to spironolactone.
Frequently Asked Questions
Common patient questions answered simply.
| Question | Action / Answer |
|---|---|
| Can I take spironolactone with my ACE inhibitor? | Yes, but only with careful baseline and repeat potassium and renal checks; speak to your GP or pharmacist before starting. |
| How long until I feel better? | Oedema and breathlessness often improve within 1–6 weeks; dermatology benefits usually take 3–6 months. |
| Will it affect my fertility or pregnancy? | Avoid in pregnancy and breastfeeding unless advised by a specialist; discuss contraception if used for acne. |
| What should I monitor at home? | Report muscle weakness, palpitations or sudden fatigue; do not take potassium supplements without advice. |
Guidelines For Proper Use
How should pharmacists counsel patients starting aldactone and where can patients find NHS support?
Counselling typically covers the indication, dosing, blood‑test schedule, key interactions and lifestyle advice such as avoiding potassium salt substitutes.
Use a monitoring checklist: confirm baseline renal function and potassium, set reminders for tests at 1–2 weeks after start/titration and then every three months if stable, and provide written guidance or NHS App signposting.
For off‑label acne prescribing, ensure documented informed consent is recorded and that shared‑care arrangements are in place if a GP continues prescriptions after specialist initiation.
Signpost patients to NHS 111 for urgent concerns, their GP for routine monitoring, community phlebotomy services for blood tests, and local dermatology or endocrine clinics for specialist care.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 5–7 days |
| Birmingham | England | 5–7 days |
| Manchester | England | 5–7 days |
| Glasgow | Scotland | 5–7 days |
| Leeds | England | 5–7 days |
| Edinburgh | Scotland | 5–7 days |
| Bristol | England | 5–9 days |
| Liverpool | England | 5–9 days |
| Cardiff | Wales | 5–7 days |
| Belfast | Northern Ireland | 5–9 days |
| Newcastle Upon Tyne | England | 5–9 days |
| Nottingham | England | 5–9 days |
| Southampton | England | 5–9 days |
| Leicester | England | 5–9 days |
| Sheffield | England | 5–9 days |